Exclusive: AI biotech Iambic snags CFO who helped steer Recursion-Exscientia dealnews2025-01-06T11:30:05+00:00January 6th, 2025|Endpoints News|
Regeneron buys London-based ocular biotechnews2025-01-02T18:46:53+00:00January 2nd, 2025|Endpoints News|
Inmagene to join Nasdaq through reverse merger with Ikenanews2024-12-23T14:55:44+00:00December 23rd, 2024|Endpoints News|
Sofinnova outlines $550M fund after IPOs and M&A dealsnews2024-12-20T16:08:52+00:00December 20th, 2024|Endpoints News|
Florida cancer biotech Syncromune raises $100M Series Anews2024-12-20T11:30:38+00:00December 20th, 2024|Endpoints News|
David Epstein gets $140M for Ottimo’s bifunctional take on hot PD-1xVEGF fieldnews2024-12-19T07:25:41+00:00December 19th, 2024|Endpoints News|
Ring Therapeutics cuts workforce in latest round of layoffs as CEO departsnews2024-12-18T14:58:47+00:00December 18th, 2024|Endpoints News|
SiteOne Therapeutics, a pain biotech that’s partnered with Vertex, nabs $100Mnews2024-12-18T12:00:41+00:00December 18th, 2024|Endpoints News|
Chicago’s biotech scene is growing up. What’s fueling it?news2024-12-17T15:28:21+00:00December 17th, 2024|Endpoints News|
